Growth arrest of melanoma cells is differentially regulated by contact inhibition and serum deprivation

DNA and Cell Biology

Volumn 18, Issue 5, 1999, Pages 357-367

  Modiano, Jaime F ^a   Ritt, Michelle G ^b   Wojcieszyn, John ^a   Smith III, Roger ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTACT INHIBITION; CONTROLLED STUDY; DOG; GENE OVEREXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; IMMUNOCYTOCHEMISTRY; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOOD; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL DIVISION; CULTURE MEDIA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOGS; G1 PHASE; MELANOMA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033061138     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315259     Document Type: Article

References (68)

1. ABBATE, M., and REMUZZI, G. (1996). Acceleration of recovery in acute renal failure: from cellular mechanisms of tubular repair to innovative targeted therapies. Renal Fail. 18, 377-388.
2. AMSLER, K. (1994). Role of cell density/cell-cell contact, and growth state in expression of differentiated properties by the LLC-PK1 cell. J. Cell. Physiol. 159, 331-339.
3. ARANY, I., FLEISCHMANN, C.M., TYRING, S.K., and FLEISCHMANN, W.R. (1997). Interferon regulates expression of mda-6/ WAF1/CIP1 and cyclin-dependent kinases independently from p53 in B16 raurine melanoma cells. Biochem. Biophys. Res. Commun. 233, 678-680.
4. ASSOIAN, R.K., and ZHU, X. (1997). Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9, 93-98.
5. BAUER, D.V., BEST, D.W., HAINSKI, A.M., and MOODY, S.A. (1996). A contact-dependent animal-to-vegetal signal biases neural lineages during Xenopus cleavage stages. Dev. Biol. 178, 217-228.
6. BERTRAM, J.S. (1990). Role of gap junctional cell/cell communication in the control of proliferation and neoplastic transformation. Radiat. Res. 123, 252-256.
7. CELLER, J.W., LUO, X., GONEZ, L.J., and BOHMER, F.D. (1995). mRNA expression of two transmembrane protein tyrosine phosphatases is modulated by growth factors and growth arrest in 3T3 fibroblasts. Biochem. Biophys. Res. Commun. 209, 614-621.
8. CHITKO-MCKOWN, C.G., and MODIANO, J.F. (1997). Clues to immune function and oncogenesis provided by events that activate the cell cycle machinery in normal human T cells. J. Leukoc. Biol. 62, 430-437.
9. COTTER, T.G., and AL-RUBEAI, M. (1995). Cell death (apoptosis) in cell culture systems. Trends Biotechnol. 13, 150-155.
10. DARZYNKIEWICZ, Z., JUAN, G., LI, X., GORCZYCA, W., MURAKAMI, T., and TRAGANOS, F. (1997). Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27, 1-20.
11. DAVOL, P.A., GOULETTE, F.A., FRACKELTON, A.R., JR., and DARNOWSKI, J.W. (1996). Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line. Cancer Res. 56, 2522-2526.
12. DENG, C., ZHANG, P., HARPER, J.W., ELLEDGE, S.J., and LEDER, P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
13. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W., and VOGELSTEIN, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
14. ELLEDGE, S.J. (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672.
15. FILIPAK, M., ESTERVIG, D.N., TZEN, C.Y., MINOO, P., HOERL, B.J., MAERCKLEIN, P.B., ZSCHUNKE, M.A., EDENS, M., and SCOTT, R.E. (1989). Integrated control of proliferation and differentiation of mesenchymal stem cells. Environ. Health Perspect. 80, 117-125.
16. FORNACE, A.J., JR., NEBERT, D.W., HOLLANDER, M.C., LUETHY, J.D., PAPATHANASIOU, M., FARGNOLI, J., and HOLBROOK, N.J. (1989). Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging reagents. Mol. Cell. Biol. 9, 4196-4203.
17. FRISCH, S.M., and FRANCIS, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
18. GOROSPE, M., WANG, X., GUYTON, K.Z., and HOLBROOK, N.J. (1996). Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol. 16, 6654-6660.
19. GUSTINCICH, S., and SCHNEIDER, C. (1993). Serum deprivation response gene is induced by serum starvation but not by contact inhibition. Cell Growth Differ. 4, 753-760.
20. HUNTER, T. (1997). Oncoprotein networks. Cell 88, 333-346.
21. HUNTER, T., and PINES, J. (1994). Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 573-582.
22. JACOBSON, M.D., WEIL, M., and RAFF, M.C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
23. JAY, V., YI, Q., HUNTER, W.S., and ZIELENSKA, M. (1996). p53 expression in uveal malignant melanomas. Pathology 28, 306-308.
24. JIANG, H., LIN, J., SU, Z.Z., HERLYN, M., KERBEL, R.S., WEISSMAN, B.E., WELCH, D.R., and FISHER, P.E. (1995). The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 10, 1855-1964.
25. JULIANO, R. (1996). Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessays 18, 911-917.
26. KANOKO, M., UEDA, M., NAGANO, T., and ICHIHASHI, M. (1996). Expression of p53 protein in melanoma progression. J. Dermatol. Sci. 12, 97-103.
27. KATO, S., SHANLEY, J.R., and FOX, J.C. (1996). Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am. J. Pathol. 149, 687-697.
28. KING, K.L., and CIDLOWSKI, J.A. (1995). Cell cycle and apoptosis: common pathways to life and death. J. Cell. Biochem. 58, 175-180.
29. LEVINE, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
30. LI, Y., JENKINS, C.W., NICHOLS, M.A., and XIONG, Y. (1994). Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261-2268.
31. LIEBERMANN, D.A., HUFFMAN, B., and STEINMAN, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199-210.
32. LINDENBOIM, L., DIAMOND, R., ROTHENBERG, E., and STEIN, R. (1995). Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res. 55, 1242-1247.
33. LOEWENSTEIN, W.R., and ROSE, B. (1992). The cell-cell channel in the control of growth. Semin. Cell Biol. 3, 59-79.
34. LOYER, P., CARIOU, S., GLAISE, D., BILODEAU, M., BAFFET, G., and GUGUEN-GUILLOUZO, C. (1996). Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro: evidence of a mitogen restriction point in mid-late G1. J. Biol. Chem. 271, 11484-11492.
35. MACLEOD, K.F., SHERRY, N., HANNON, G., BEACH, D., TOKINO, T., KINZLER, K., VOGELSTEIN, B., and JACKS, T. (1995). p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9, 935-944.
36. MASTRANGELO, A.J., and BETENBAUGH, M.J. (1995). Implications and applications of apoptosis in cell culture. Curr. Opin. Biotechnol. 6, 198-202.
37. MIMURA, N., ICHIKAWA, K., ASANO, A., NAGASE, T., and ISHII, S. (1996). A transient increase of snoN transcript by growth arrest upon serum deprivation and cell-to-cell contact. FEBS Lett. 397, 253-259.
38. MODIANO, J.F., DOMENICO, J., SZEPESI, A., LUCAS, J.J., and GELFAND, E.W. (1994). Differential requirements for interleukin2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269, 32972-32978.
39. MODIANO, J.F., DOMENICO, J., SZEPESI, A., TERADA, N., LUCAS, J.J., and GELFAND, E.W. (1995). Symmetry of the activation of cyclin-dependent kinases in mitogen and growth factor-stimulated T lymphocytes. Ann. NY Acad. Sci. 766, 134-148.
40. MODIANO, J.F., KOKAI, Y., WEINER, D.B., PYKETT, M.J., NOWELL, P.C., and LYTTLE, C.R. (1991). Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line. J. Cell. Biochem. 45, 196-206.
41. MOORE, W.A. (1992). Experience in cell line testing. Dev. Biol. Stand. 76, 51-56.
42. MURDOCH, A., JENKINSON, E.J., JOHNSON, G.D., and OWEN, J.J.T. (1990). Alkaline phosphatase-fast red, a new fluorescent label. J. Immunol. Methods 132, 45-49.
43. NAKANISHI, M., ADAMI, G.R., ROBETORYE, R.S., NODA, A., VENABLE, S.F., DIMITROV, D., PEREIRA-SMITH, O.M., and SMITH, J.R. (1995). Exit from GO and entry into the cell cycle of cells expressing p21/sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92, 4352-4356.
44. NAKANO, S., and TS'O, P.O. (1981). Cellular differentiation and neoplasia: characterization of subpopulations of cells that have neoplasia-related growth properties in Syrian hamster embryo cell cultures. Proc. Natl. Acad. Sci. USA 78, 4995-4999.
45. PAULOVICH, A.C., TOCZYSKI, D.P., and HARTWELL, L.H. (1997). When checkpoints fail. Cell 88, 315-321.
46. POUMAY, Y., and PITTELKOW, M.R. (1995). Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Dermatol. 104, 271-276.
47. PROKOCIMER, M., and ROTTER, V. (1994). Structure and function of p53 in normal cells and their aberrations in cancer cells: projections on the hematologic cell lineages. Blood 84, 2391-2411.
48. RAWSON, C.L., LOO, D.T., DUIMSTRA, J.R., HEDSTROM, O.R., SCHMIDT, E.E., and BARNES, D.W. (1991). Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J. Cell Biol. 113, 671-680.
49. RITT, M.G., WOJCIESZYN, J., and MODIANO, J.F. (1998). Functional loss of p21/Waf-1 in a case of benign canine multicentric melanoma. Vet. Pathol. 35, 94-101.
50. ROSS, D.A., and WILSON, G.D. (1997). Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma. Br. J. Surg. 84, 803-807.
51. RUOSLAHTI, E., and REED, J.C. (1994). Anchorage dependence, integrins, and apoptosis. Cell 77, 477-478.
52. SAVILL, J., FADOK, V., HENSON, P., and HASLETT, C. (1993). Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14, 131-136.
53. SERRANO, M., HANNON, G.J., and BEACH, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
54. SERRANO, M., LIN, A.W., MCCURRACH, M.E., BEACH, D., and LOWE, S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16 ink4a. Cell 88, 593-602.
55. SHERR, C.J., and ROBERTS, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
56. SOKOL, S.Y. (1994). The pregastrula establishment of gene expression pattern in Xenopus embryos: requirements for local cell interactions and for protein synthesis. Dev. Biol. 166, 782-788.
57. VIDAL, M.J., LOGANZO, F., JR., DE OLIVEIRA, A.R., HAYWARD, N.K., and ALBINO, A.P. (1995). Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res. 5, 243-250.
58. WALDMAN, T., KJNZLER, K.W., and VOGELSTEIN, B. (1995). p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190.
59. WALDMAN, T., LENGAUER, C., KJNZLER, K.W., and VOGELSTEIN, B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
60. WANG, J., and WALSH, K. (1996). Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359-361.
61. WEISS, J., CAVENEE, W.K., HERBST, R.A., JUNG, E.G., and ARDEN, K.C. (1994). Point mutations and allelic loss in the TP53 locus of cutaneous malignant melanomas. Arch. Dermatol. Res. 286, 417-419.
62. WEISS, J., SCHWECHHEIMER, K., CAVENEE, W.K., HERLYN, M., and ARDEN, K.C. (1993). Mutation and expression of the p53 gene in malignant melanoma cell lines. Int. J. Cancer 54, 693-699.
63. WILLE, J.J., JR., MAERCKLElN, P.B., and SCOTT, R.E. (1982). Neoplastic transformation and defective control of cell proliferation and differentiation. Cancer Res. 42, 5139-5146.
64. WILLE, J.J., JR., and SCOTT, R.E. (1982). Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1 phase of the cell cycle. J. Cell. Physiol. 112, 115-122.
65. WINSTON, J.T., and PLEDGER, W.J. (1993). Growth factor regulation of cyclin D1 mRNA expression through protein synthesisdependent and -independent mechanisms. Mol. Biol. Cell 4, 1133-1144.
66. XIONG, Y., HANNON, G.J., ZHANG, H., CASSO, D., KOBAYASHL, R., and BEACH, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
67. YONISH-ROUACH, E., GRUNWALD, D., WILDER, S., KIMCHI, A., MAY, E., LAWRENCE, J.J., MAY, P., and OREN, M. (1993). p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13, 1415-1423.
68. ZHANG, W., GRASSO, L., MCCLAIN, C.D., GAMBEL, A.M., CHA, Y., TRAVALI, S., DEISSEROTH, A.B., and MERCER, W.E. (1995). p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55, 668-674.